Immuron (IMRN) EBITDA Margin (2016 - 2024)
Immuron's (IMRN) quarterly EBITDA Margin came in at 85.76% in Q4 2023, down 2533.0% year-on-year from 3.52% in Q4 2022, and up 94.26% quarter-over-quarter from 1494.83% in Q2 2023.
Immuron (IMRN) EBITDA Margin (2016 - 2024) Analysis & Trends
Immuron's EBITDA Margin history runs 8 years deep, the most recent figure standing at 85.76% for Q4 2023.
- On a quarterly basis, EBITDA Margin fell 2533.0% year-over-year to 85.76% in Q4 2023; TTM through Dec 2023 was 119.91%, a 10516.0% decrease from a year earlier, with the FY2025 full-year figure at 73.34%, up 4498.0% from the prior year.
- EBITDA Margin advanced to 85.76% in Q4 2023 per IMRN's latest filing, from 1494.83% in the prior quarter.
- Across five years, EBITDA Margin topped out at 0.64% in Q4 2019 and bottomed at 386482536.77% in Q4 2020.
- The 5-year median for EBITDA Margin is 436.99% (2021), against an average of 64414161.11%.
- Across the five-year window, EBITDA Margin plunged 2000000000 bps in 2020 and jumped 2000000000 bps in 2021, its largest moves.
- Year by year, EBITDA Margin stood at 0.64% in 2019, then plunged by 2000000000 bps to 386482536.77% in 2020, then jumped by 100 bps to 788.22% in 2021, then soared by 92 bps to 60.43% in 2022, then slumped by 42 bps to 85.76% in 2023.
- Per Business Quant, the three latest IMRN EBITDA Margin figures stand at 85.76% (Q4 2023), 1494.83% (Q2 2023), and 60.43% (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 20,861,481,670,048.55% |
| Dec 31, 2023 | -85.76% |
| Jun 30, 2023 | -1,494.83% |
| Dec 31, 2022 | -64.95% |
| Dec 31, 2021 | -788,216,345.40% |
| Dec 31, 2020 | -400,005,176.34% |
| Dec 31, 2019 | -636,308.73% |
| Dec 31, 2018 | -161.71% |
| Dec 31, 2017 | 401.31% |
| Dec 31, 2016 | 481.82% |
| Jun 30, 2016 | 501.82% |